Ideaya Biosciences Inc (NASDAQ: IDYA) established initial surge of 5.18% at $21.73, as the Stock market unbolted on Thursday, before settling in for the price of $20.66 at the close. Taking a more long-term approach, IDYA posted a 52-week range of $19.96-$47.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.23% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -0.01%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.68%. This publicly-traded company’s shares outstanding now amounts to $86.50 million, simultaneously with a float of $78.52 million. The organization now has a market capitalization sitting at $1.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $24.21, while the 200-day Moving Average is $32.61.
Ideaya Biosciences Inc (IDYA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Ideaya Biosciences Inc industry. Ideaya Biosciences Inc’s current insider ownership accounts for 10.30%, in contrast to 100.99% institutional ownership. Preceding that transaction, on May 29 ’24, Company’s Chief Scientific Officer sold 28,500 for 36.24, making the whole transaction’s value amount to 1,032,884. This particular insider is now the holder of 0 in total.
Ideaya Biosciences Inc (IDYA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
Ideaya Biosciences Inc’s EPS increase for this current 12-month fiscal period is 16.68% and is forecasted to reach -2.82 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.27% through the next 5 years, which can be compared against the -0.01% growth it accomplished over the previous five years trading on the market.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Let’s observe the current performance indicators for Ideaya Biosciences Inc (IDYA). It’s Quick Ratio in the last reported quarter now stands at 14.97. The Stock has managed to achieve an average true range (ATR) of 1.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 271.74.
In the same vein, IDYA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.30, a figure that is expected to reach -0.67 in the next quarter, and analysts are predicting that it will be -2.82 at the market close of one year from today.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
Now, what If we examine the latest scores posted by [Ideaya Biosciences Inc, IDYA]. During the last 5-days, its volume was better the volume of 0.9 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 18.39% While, its Average True Range was 1.13.
Raw Stochastic average of Ideaya Biosciences Inc (IDYA) in the period of the previous 100 days is set at 13.93%, which indicates a major fall in contrast to 31.44% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.65% that was higher than 47.99% volatility it exhibited in the past 100-days period.
